Product information
From Health Canada
No match found
No other product was found from this company.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2017-06-13
Original market date: See footnote 1
1993-12-31
Lot number: See footnote 2
5000083A
Expiry date: See footnote 2
2015-09-13
Product name:
DANTRIUM CAPSULES
DIN:
01997653
Product Monograph/Veterinary Labelling:
Date:
2015-02-19
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
PAR PHARMACEUTICAL COMPANIES
Six Ram Ridge Road
Chestnut Ridge
New York
United States
10977
Class:
Human
Dosage form(s):
Capsule
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
12:20.08
Anatomical Therapeutic Chemical (ATC): See footnote 4
M03CA01 DANTROLENE
Active ingredient group (AIG) number:See footnote5
0109855001
Active ingredient(s) | Strength |
---|---|
DANTROLENE SODIUM | 100 MG |